Colgate-Palmolive Company (NYSE:CL – Get Free Report) EVP Gregory Malcolm sold 4,100 shares of the company’s stock in a transaction on Tuesday, November 10th. The stock was sold at an average price of $97.97, for a total transaction of $401,677.00. Following the transaction, the executive vice president owned 10,061 shares of the company’s stock, valued at $985,676.17. This represents a 28.95% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
Colgate-Palmolive Price Performance
CL traded down $0.16 during midday trading on Thursday, hitting $97.84. 3,153,922 shares of the company traded hands, compared to its average volume of 5,619,070. The business has a 50 day simple moving average of $90.59 and a two-hundred day simple moving average of $90.16. Colgate-Palmolive Company has a 52-week low of $75.96 and a 52-week high of $101.18. The company has a market capitalization of $77.77 billion, a price-to-earnings ratio of 38.37, a PEG ratio of 4.44 and a beta of 0.31. The company has a current ratio of 0.96, a quick ratio of 0.63 and a debt-to-equity ratio of 11.23.
Colgate-Palmolive (NYSE:CL – Get Free Report) last released its earnings results on Friday, October 30th. The company reported $0.97 EPS for the quarter, topping analysts’ consensus estimates of $0.93 by $0.04. Colgate-Palmolive had a net margin of 9.65% and a return on equity of 607.88%. The business had revenue of $5.37 billion during the quarter, compared to analysts’ expectations of $5.34 billion. During the same quarter in the previous year, the company earned $0.91 earnings per share. The company’s quarterly revenue was up 4.6% on a year-over-year basis. On average, equities analysts forecast that Colgate-Palmolive Company will post 3.92 earnings per share for the current fiscal year.
Colgate-Palmolive Dividend Announcement
Institutional Investors Weigh In On Colgate-Palmolive
Large investors have recently made changes to their positions in the stock. Virginia Estate & Retirement Planning Advisors Inc. lifted its position in Colgate-Palmolive by 1,409.1% during the third quarter. Virginia Estate & Retirement Planning Advisors Inc. now owns 332 shares of the company’s stock worth $28,000 after buying an additional 310 shares in the last quarter. Parvin Asset Management LLC purchased a new stake in shares of Colgate-Palmolive in the second quarter valued at about $32,000. Park Place Capital Corp grew its holdings in shares of Colgate-Palmolive by 55.5% in the second quarter. Park Place Capital Corp now owns 356 shares of the company’s stock valued at $33,000 after purchasing an additional 127 shares during the period. Gould Capital LLC increased its position in Colgate-Palmolive by 38.7% during the first quarter. Gould Capital LLC now owns 412 shares of the company’s stock worth $35,000 after purchasing an additional 115 shares during the last quarter. Finally, Montgomery Financial Services LLC acquired a new stake in Colgate-Palmolive during the second quarter worth about $36,000. 80.41% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Several research firms have commented on CL. Piper Sandler cut their price objective on Colgate-Palmolive from $98.00 to $95.00 and set an “overweight” rating for the company in a research note on Monday, September 21st. Weiss Ratings downgraded Colgate-Palmolive from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Friday, October 2nd. Royal Bank Of Canada lifted their price target on Colgate-Palmolive from $104.00 to $105.00 and gave the stock an “outperform” rating in a research note on Monday, November 2nd. Bank of America boosted their price target on Colgate-Palmolive from $100.00 to $105.00 and gave the stock a “buy” rating in a research report on Monday, November 2nd. Finally, Barclays increased their price objective on Colgate-Palmolive from $87.00 to $95.00 and gave the company an “equal weight” rating in a research note on Tuesday, November 3rd. Thirteen analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $101.22.
View Our Latest Analysis on CL
Colgate-Palmolive Company Profile
Colgate-Palmolive is a global consumer products company whose business spans oral care, personal care, home care and pet nutrition. Its products include toothpaste, toothbrushes, mouthwashes, soaps, shampoos, cleaning products and pet food. The company’s best-known brands include Colgate, Palmolive, elmex, Softsoap, Ajax and Hill’s Pet Nutrition. It sells products through retail and other channels in markets around the world. Founded in 1806 by William Colgate as a soap and candle business in New York City, the company has grown into an international manufacturer of household and personal care products.
Featured Stories
- Five stocks we like better than Colgate-Palmolive
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
- Midterm Fallout, NVIDIA Turmoil, Anthropic’s IPO: Is Broadcom a Steal?
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
